| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 12 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 3 | DOXORUBICIN | 11 |
| 4 | METHOTREXATE | 10 |
| 5 | METHOTREXATE SODIUM | 10 |
| 6 | DEXAMETHASONE | 9 |
| 7 | DEXAMETHASONE 1.5 MG | 9 |
| 8 | CISPLATIN | 8 |
| 9 | CYTARABINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLUCARPIDASE | 1 | 0.0028 |
| 1 | EPCORITAMAB-BYSP | 3 | 0.0022 |
| 2 | POLATUZUMAB VEDOTIN | 7 | 0.0007 |
| 3 | BENDAMUSTINE HCL | 6 | 0.0004 |
| 4 | SALINE NASAL SPRAY | 1 | 0.0002 |
| 5 | CYTARABINE | 8 | 0.0001 |
| 6 | GEMCITABINE HYDROCHLORIDE | 7 | 0.0001 |
| 7 | DOXORUBICIN | 11 | 0.0001 |
| 8 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 9 | CISPLATIN | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 3 | 0.0007 |
| 2 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 12 | 0.0000 |
| 4 | Iron Chelator [EPC] | 1 | 0.0000 |
| 5 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Janus Kinase Inhibitor [EPC] | 5 | 0.0000 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 8 | 0.0000 |